Oxbryta Will Be a New Specialty Med for Sickle Cell Disease
Oxbryta (oks-BRYE-tuh, voxelotor) will be a new oral tablet to treat sickle cell disease in patients 12 years and older.
Oxbryta may be added to hydroxyurea...which is often used first for sickle cell patients to reduce pain crises, hospitalizations, and possibly improve survival.
But don't expect to stock Oxbryta. It's a specialty Rx...and costs about $10,000/month.